Long-term abstinence from alcohol in patients receiving aversion therapy as part of a multimodal inpatient program.

Schick Shadel Hospital, Seattle, Washington, United States
Journal of Substance Abuse Treatment (Impact Factor: 3.14). 02/1990; 7(2):77-82. DOI: 10.1016/0740-5472(90)90002-8
Source: PubMed

ABSTRACT A sample of 200 patients who had been treated for alcoholism in a multimodal inpatient program that used aversion therapy as a treatment component was selected for outcome evaluation. One hundred sixty (80%) were located. A minimum of 13 months had elapsed since treatment (mean 20.5 months) collateral reports were used to verify self-reports in 36% of the cases. Abstinence status was determined for the first 12 months since treatment, the entire elapsed time since treatment (range 13 to 25 months, mean 20.5 months), and "current abstinence" (last 6 months). The abstinence rate for the first 12 months was 71.3%; for the total period since treatment, the rate was 65% (mean 20.5 months); the current abstinence rate was 78.1%. The data was also viewed from other perspectives. The findings of this study suggest that a multimodal alcoholism treatment program utilizing aversion conditioning is at least as acceptable to patients as counseling centered programs and can be expected to yield favorable abstinence rates.


Available from: Patrick Joseph Frawley, May 29, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is a paucity of research on pharmacotherapies in adolescents with substance use disorders. This paucity is partly because of the fact that most people with substance dependence do not get diagnosed until early adulthood, that is, after 18 years of age. This article reviews pharmacotherapies used for aversion, substitution, anti-craving, and detoxification of alcohol, nicotine, cocaine, and opioids dependence. Adult research is referenced when applicable and generalized to adolescents with caution. Continued evaluation and development of pharmacotherapy for youth in controlled studies are needed to examine medication effectiveness, safety, potential for abuse, compliance, and potential interactions with other medications or substances of abuse.
    Child and adolescent psychiatric clinics of North America 07/2010; 19(3):591-608. DOI:10.1016/j.chc.2010.03.010 · 2.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The United States Army Alcohol and Drug Treatment outpatient Program in Augsburg, Germany, conducted a single site treatment evaluation study. Alcohol education, stress management, and values clarification were rated by patients as the most helpful treatment elements. In spite of limited statistical significance, this study suggests patients may benefit from a highly structured, intense psychoeducational rehabilitation program which utilizes a cognitive-behavioral approach.
    Alcoholism Treatment Quarterly 01/1995; 12(4):89-95. DOI:10.1300/J020V12N04_08
  • [Show abstract] [Hide abstract]
    ABSTRACT: Eighty-two hospitalized alcoholics receiving pharmacological aversion therapy (PAT) over a 10-day treatment interval completed cognitive, behavioral, and psychophysiological measures evaluating conditioned aversion to alcohol. Pre-post assessments provided convergent support for the efficacy of PAT vis-à-vis production of conditioned aversion to alcohol. Positive alcoholrelated outcome expectancies were significantly reduced, whereas confidence that drinking could be avoided in various high-risk situations for consumption was increased following PAT. Behavioral and cardiac rate assessments revealed significant changes following PAT that were specific to alcoholic beverages and potentially reflective of conditioned alcohol aversion. Patients with more extensive pretreatment experiences with alcohol-associated nausea and greater involvement in antisocial conduct appeared to be less susceptible to the PAT conditioning protocol.
    The American Journal of Drug and Alcohol Abuse 07/2009; 27(3). DOI:10.1081/ADA-100104519 · 1.47 Impact Factor